Eyenuk is an AI eye screening service provider, focusing on artificial intelligence and eye disease monitoring, and is committed to providing users with eye disease screening services such as retinopathy, glaucoma, and macular degeneration. Recently, Eyenuk received $26 million in Series A financing from AXA Investment Managers.
This article is reproduced from: https://www.itjuzi.com/investevent/13606730
This site is for inclusion only, and the copyright belongs to the original author.